Clonidine and Pancytopenia aggravated - a phase IV clinical study of FDA data
Summary:
We study 60,680 people who have side effects when taking Clonidine. Pancytopenia aggravated is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Amlodipine and have Multiple myeloma.
The phase IV clinical study analyzes which people take Clonidine and have Pancytopenia aggravated. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
60,680 people reported to have side effects when taking Clonidine.
Among them, 230 people (0.38%) have Pancytopenia aggravated.
What is Clonidine?
Clonidine has active ingredients of clonidine. It is used in high blood pressure. Currently, eHealthMe is studying from 62,360 Clonidine users.
What is Pancytopenia aggravated?
Pancytopenia aggravated (serious medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets) is found to be associated with 1,462 drugs and 513 conditions by eHealthMe. Currently, we are studying 16 people who have Pancytopenia aggravated.
Number of Clonidine and Pancytopenia aggravated reports submitted per year:
Time on Clonidine when people have Pancytopenia aggravated *:
Gender of people who have Pancytopenia aggravated when taking Clonidine*:
Age of people who have Pancytopenia aggravated when taking Clonidine *:
Common drugs people take besides Clonidine *:
Common side effects people have besides Pancytopenia aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Clonidine and have Pancytopenia aggravated?
Check whether Pancytopenia aggravated is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
Related studies
Clonidine side effects by duration, gender and age:
- Clonidine side effects (62,360 reports)
Pancytopenia aggravated treatments and more:
- Pancytopenia aggravated (16 reports)
Common drugs associated with Pancytopenia aggravated:
- Methotrexate: 6,338 reports
- Prednisone: 5,090 reports
- Carboplatin: 3,268 reports
- Prednisolone: 3,153 reports
- Dexamethasone: 2,697 reports
- Aspirin: 2,560 reports
- Omeprazole: 2,440 reports
- Lopurin: 2,361 reports
- Allopurinol: 2,360 reports
- Furosemide: 2,339 reports
All the drugs that are associated with Pancytopenia aggravated:
- Pancytopenia aggravated (1,462 drugs)
Common conditions associated with Pancytopenia aggravated:
- Multiple myeloma: 4,988 reports
- Rheumatoid arthritis: 3,378 reports
- High blood pressure: 2,396 reports
- Pain: 1,731 reports
- Hepatitis c: 1,212 reports
- Preventive health care: 1,207 reports
All the conditions that are associated with Pancytopenia aggravated:
- Pancytopenia aggravated (513 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on clonidine (the active ingredients of Clonidine) and Clonidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Humatrope and Lescol drug interaction - 6 seconds ago
- Ergocalciferol and Isosorbide Mononitrate drug interaction - 27 seconds ago
- Cubicin and Muscle Twitching - 27 seconds ago
- Sodium Bicarbonate and Arimidex drug interaction - 47 seconds ago
- Effexor and Methoxsalen drug interaction - 47 seconds ago
- Sotalol Hydrochloride and Thrombocytopenia - 48 seconds ago
- Milk Of Magnesia and Cholecystitis - a minute ago
- Albuterol and Cerebral Calcification - a minute ago
- Saphris and Skin Blushing/Flushing - a minute ago
- Bricanyl and Ketoprofen drug interaction - a minute ago